Tetrakis(4-N-methylpyridyl)porphine(38673-65-3)
- Name: Tetrakis(4-N-methylpyridyl)porphine
- Synonyms:tmpyp4;Tetra(4-N-methylpyridyl)porphine;5,10,15,20-tetrakis-(N-methyl-pyridinium-4-yl)-21H,23H-porphyrin cation;tetrakis(4-N-methylpyridyl)porphyrin;TMPYP;meso-tetrakis(N-methylpyridinium-4-yl)porphyrin;meso-Tetrakis(N-methyl-4-pyridinium)phenyl porphyrin;meso-tetrakis(1-methylpyridin-1-ium-4-yl)porphyrin;Tetrakis(4-N-methylpyridyl)porphine;meso-Tetrakis(2-N-methylpyridyl)porphine;5,10,15,20-tetrakis(1-methylpyridin-1-ium-4-yl)-21,22-dihydroporphyrin;Mesotetra(4-N-methylpyridyl)porphine;Tetrakis(N-methyl-4-pyridino)porphine;
- Molecular Formula:C44H38N8+4
- Molecular Weight:678.82612
- CAS Registry Number:38673-65-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.38673-65-3 Tetrakis(4-N-methylpyridyl)porphine
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.38673-65-3 5,10,15,20-tetrakis(1-methylpyridin-1-ium-4-yl)-21,22-dihydroporphyrin
Assay:97% Appearance:white powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States] CAS No.38673-65-3 meso-Tetrakis(2-N-methylpyridyl)porphine
Assay:98.5% Appearance:white/off-white or light yellow Package:aluminum bottle,glass bottle,PTFE bottle,cardboard drum Storage:Store in cool and dry place, keep away from strong light and heat. Transportation:by courier, by air, by sea Application:This product can be used in food/pharmaceutical/cosmetical industry
Min. Order:0
Supplier:Suzhou Health Chemicals Co., Ltd. [
China (Mainland)]
Other Product
- 33147-93-2/Acutuminol A
- 75278-78-3/55963-78-5
- 20978-98-7/3-(4-Chlorophenyl)-2H-1,3-benzoxazin-4(3H)-one
- 85188-05-2/dimethyl[4-[[4-(dimethylamino)phenyl]benzylidene]-2,5-cyclohexadien-1-ylidene]ammonium sulphate (2:1)
- 116-43-8/p-2-Thiazolylsulfamoylsuccinanilic acid
- 5901-34-8/(5E)-3-benzyl-5-{4-[(4-fluorobenzyl)oxy]-3-methoxybenzylidene}-2-thioxo-1,3-thiazolidin-4-one
- 13860-64-5/2-(1-methylpiperidin-2-yl)-1,1-diphenylethyl propanoate hydrochloride (1:1)
- 149127-53-7/Ovaprim
- 20000-30-0/benzenepropanol, 4-hydroxy-3-methoxy-alpha-methyl-
- 101517-12-8/1,1,1-trifluoro-3-[(E)-(hydroxyimino)methyl]-2-(trifluoromethyl)octan-2-ol
- 138570-50-0/tripterygone
- 34675-74-6/(1-phenylethyl)hydrazine ethanedioate (1:1)
- 27154-67-2/pentanal
- 68814-91-5/Alkenes, C5-9 alpha-
- 302-27-2/Aconitine
- 49755-67-1/ioglicic acid
- 33354-22-2/5-Chloro-3-[[(4-methylpiperazin-1-yl)carbonyl]methyl]benzothiazol-2(3H)-one
- 66641-83-6/S-ethyl 1-(1-phenylethyl)-1H-imidazole-5-carbothioate hydrochloride
- 28821-89-8/6,14-Ethenomorphinan-7-methanol,4,5-epoxy-3,6-dimethoxy-a,17-dimethyl-, (5a,7a)- (9CI)
- 38673-65-3/Tetrakis(4-N-methylpyridyl)porphine
- 5440-53-9/diethyl 2-acetamido-2-[(2-methylphenyl)methyl]propanedioate
- 1769-41-1/glyoxylanilide,2-oxime
- 145733-36-4/Tasosartan
- 68608-76-4/Benzamide, N-(3-aminopropyl)-2-hydroxy-, N-coco alkyl derivs.
- 112515-27-2/2-Pyrrolidinecarboxamide,1-methyl-N-[2-(2,3,4-tribromo-5-methoxyphenyl)ethyl]-, (2S)-
- 576-68-1/mannomustine
- 64624-63-1/Urea,N,N''-1,3-propanediylbis[N'-cyclohexyl-N-nitroso- (9CI)
- 147362-23-0/D-arabino-Hexitol,1,5-dideoxy-6-C-[(S)-2-[5-oxazolyl[(1-oxopentadecyl)oxy]methyl]-4-oxazolyl]-,(6S)-
- 6957-91-1/4-aminobenzaldehyde thiosemicarbazone
- 961-88-6/4-(3-PHENYL-4,5-DIHYDRO-PYRAZOL-1-YL)-BENZALDEHYDE